help button home button The Oncologist http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Ethical Conflict in Providing Informed Consent for Clinical Trials: A Probl...
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Markman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Markman, M.
The Oncologist, Vol. 9, No. 1, 3–7, February 2004
© 2004 AlphaMed Press


COMMENTARY

Ethical Conflict in Providing Informed Consent for Clinical Trials: A Problematic Example from the Gynecologic Cancer Research Community

Maurie Markman

Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA

Correspondence: Maurie Markman, M.D., Department of Hematology/Medical Oncology (R35), The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA. Telephone: 216-445-6888; Fax: 216-444-9464; e-mail: markmam{at}ccf.org

The principle of respect for patient autonomy and the importance of informed consent are well established in the conduct of clinical research. However, in actual clinical practice, how one applies this concept is not always clear. The provocative results of a randomized trial examining "consolidation/maintenance" therapy in women with advanced ovarian cancer who achieved a clinically defined complete response to primary chemotherapy have raised difficult issues for clinicians and clinical investigators regarding their obligations to provide patients with information that may interfere with the conduct of ongoing or future research studies.

Key Words. Ovarian cancer • Paclitaxel • Randomized trials • Informed consent in clinical research




This article has been cited by other articles:


Home page
IOVSHome page
T. Nagai, H. Imai, S. Honda, and A. Negi
Antiangiogenic Effects of Bisphosphonates on Laser-Induced Choroidal Neovascularization in Mice
Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5716 - 5721.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Sonnemann, B. Bumbul, and J. F. Beck
Synergistic activity of the histone deacetylase inhibitor suberoylanilide hydroxamic acid and the bisphosphonate zoledronic acid against prostate cancer cells in vitro
Mol. Cancer Ther., November 1, 2007; 6(11): 2976 - 2984.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Peng, Y. Sohara, R. A. Moats, M. D. Nelson Jr., S. G. Groshen, W. Ye, C. P. Reynolds, and Y. A. DeClerck
The Activity of Zoledronic Acid on Neuroblastoma Bone Metastasis Involves Inhibition of Osteoclasts and Tumor Cell Survival and Proliferation
Cancer Res., October 1, 2007; 67(19): 9346 - 9355.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. S. Choe, Z. Chen, C. M. Klass, X. Zhang, and D. M. Shin
Enhancement of Docetaxel-Induced Cytotoxicity by Blocking Epidermal Growth Factor Receptor and Cyclooxygenase-2 Pathways in Squamous Cell Carcinoma of the Head and Neck
Clin. Cancer Res., May 15, 2007; 13(10): 3015 - 3023.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. P. Crume, J. H. Miller, and A. C. La Flamme
Peloruside A, an Antimitotic Agent, Specifically Decreases Tumor Necrosis Factor-{alpha} Production by Lipopolysaccharide-Stimulated Murine Macrophages
Experimental Biology and Medicine, May 1, 2007; 232(5): 607 - 613.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. N. Shajahan, A. Wang, M. Decker, R. D. Minshall, M. C. Liu, and R. Clarke
Caveolin-1 Tyrosine Phosphorylation Enhances Paclitaxel-mediated Cytotoxicity
J. Biol. Chem., February 23, 2007; 282(8): 5934 - 5943.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. Daubine, C. Le Gall, J. Gasser, J. Green, and P. Clezardin
Antitumor Effects of Clinical Dosing Regimens of Bisphosphonates in Experimental Breast Cancer Bone Metastasis
J Natl Cancer Inst, February 21, 2007; 99(4): 322 - 330.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. J. Roelofs, K. Thompson, S. Gordon, and M. J. Rogers
Molecular mechanisms of action of bisphosphonates: current status.
Clin. Cancer Res., October 15, 2006; 12(20): 6222s - 6230s.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
G Sanna, L Preda, R Bruschini, M Cossu Rocca, S Ferretti, L Adamoli, E Verri, L Franceschelli, A Goldhirsch, and F Nole
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer
Ann. Onc., October 1, 2006; 17(10): 1512 - 1516.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. D. Colevas
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
J. Clin. Oncol., June 10, 2006; 24(17): 2644 - 2652.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S.-B. Woo, J. W. Hellstein, and J. R. Kalmar
Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws
Ann Intern Med, May 16, 2006; 144(10): 753 - 761.
[Abstract] [Full Text] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
K. Mystakidou, E. Katsouda, E. Parpa, E. Kouskouni, C. Chondros, M. L. Tsiatas, A. Galanos, and L. Vlahos
A prospective randomized controlled clinical trial of zoledronic acid for bone metastases
American Journal of Hospice and Palliative Medicine, January 1, 2006; 23(1): 41 - 50.
[Abstract] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/misc/eLetters.shtml

Copyright © 2004 by AlphaMed Press.